Fiche centre
Atlanta — centre non communiqué
Atlanta — United States
Essais liés3clinical trials
VilleAtlantalocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT02257736
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| M106 VNS Therapy System | SEP | Non applicable | NCT01846741 | VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37) | COMPLETED |
| Apalutamide | Cancer | Phase 3 | NCT02257736 | An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) | ACTIVE_NOT_RECRUITING |
| ACP-103 | Parkinson | Phase 2 | NCT00087542 | Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug | COMPLETED |